RSS

trial results

A new study from Tufts Center for the Study of Drug Development highlights the need to transform clinical data management practices to enable risk-based approaches and reveals the root causes for delays and inefficiencies impacting trial timelines Read more

News

AstraZeneca and its global biologics research and development arm, MedImmune, have announced positive overall survival (OS) results of the Phase III PACIFIC trial evaluating Imfinzi (durvalumab) for the treatment of unresectable stage III NSCL Read more

News

Researchers from the University of Manchester and Salford Royal NHS Foundation Trust have found that an anti-inflammatory drug, used to treat RA, reduces harmful inflammation when administered to patients in the early stages of stroke Read more

News

New data, presented at the 2018 American Academy of Dermatology (AAD) Annual Meeting, has demonstrated that Tremfya (guselkumab) provides long-term skin clearance in patients with moderate to severe plaque psoriasis. Read more

News

Researchers from the UCL Huntington’s Disease Centre have developed a drug that has been shown to be safe and well-tolerated in its first human trial, successfully lowering the level of harmful huntingtin protein in the nervous system Read more

News

Axovant Sciences, a clinical-stage biopharmaceutical company, has revealed negative topline results of its Phase III MINDSET trial in Alzheimer’s disease, but the CEO has stressed that the company will continue advancing its pipeline Read more

News